How confident are you in your disease area strategy?
Leading a disease area strategy means making decisions that shape multiple brands, customers, priorities and investments.
Having confidence that your strategy is aligned, actionable and positioned to deliver stronger performance across your portfolio is critical.
The Prescient Disease Area Strategy Impact Index provides senior leaders with an independent perspective to help strengthen strategy, improve decision making and identify opportunities to deliver industry best practice.
Supported by AI and powered by Prescient’s strategy specialists, every assessment combines technology with deep strategic expertise and practical experience across disease areas, portfolios and markets.
Why are senior pharma leaders adopting the Disease Area Strategy Impact Index?
Drive stronger portfolio performance
Strengthen alignment across brands, customers and markets to maximise the performance of your disease area strategy.
Make strategic decisions with greater confidence
Gain an independent perspective on your strategy before major planning, investment and implementation decisions.
Identify opportunities to deliver industry best practice
Understand where opportunities exist to strengthen strategic effectiveness, improve execution and drive greater impact.
Align stakeholders around one strategy
Create greater alignment across functions, brands and teams to support more connected decision making and execution.
Save valuable time
Receive an independent strategic review in days, helping avoid lengthy internal review cycles and alignment workshops while accelerating strategic decision making.
Led by Prescient’s strategy experts
The Prescient Disease Area Strategy Impact Index is pioneered by Stephanie Hall, Chief Strategy and Innovation Officer, and supported by Prescient’s experienced strategy specialists.
Supported by AI and powered by expert review, it helps organisations strengthen disease area strategy, improve decision making and maximise performance across multiple brands and customer types.
How confident are you in your disease area strategy?
